当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Oncologists tap the microbiome in bid to improve immunotherapy outcomes
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-02-16 , DOI: 10.1038/nrd.2018.19
Asher Mullard

Oncologists tap the microbiome in bid to improve immunotherapy outcomes

Oncologists tap the microbiome in bid to improve immunotherapy outcomes, Published online: 16 February 2018; doi:10.1038/nrd.2018.19

A pioneering Merck & Co.-funded study is set to explore the ability of the microbiome to boost immuno-oncology therapy outcomes, and other companies are quickly gearing up to enter this clinical space.


中文翻译:

肿瘤学家利用微生物组来改善免疫治疗效果

肿瘤学家利用微生物组来改善免疫治疗效果

肿瘤学家挖掘微生物组以改善免疫治疗效果,在线发表于:2018年2月16日; doi:10.1038 / nrd.2018.19

由默克公司(Merck&Co.)资助的一项具有开创性的研究旨在探索微生物组增强免疫肿瘤治疗结果的能力,其他公司也正在迅速加紧准备进入这一临床领域。
更新日期:2018-02-16
down
wechat
bug